PRIMARY STUDY
The value of Rowatinex in the treatment of ureterolithiasis
Key Findings: A higher success rate was noted in the Rowatinex group when compared to the placebo group, although this was not statistically significant.
Type of Study: Double Blind Clinical Trial
Study Result: Positive
Study Location(s): Israel
Year of Pub: 1987
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: Borneol, Eucalyptol, Pinene
